<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Dishman Carbogen Amcis Ltd. — News on 6ix</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited</link>
<description>Latest news and press releases for Dishman Carbogen Amcis Ltd. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 05 May 2026 14:03:41 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/dishman-carbogen-amcis-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68364a1f78dffbe2df152c97.webp</url>
<title>Dishman Carbogen Amcis Ltd.</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited</link>
</image>
<item>
<title>Press Release May 05 2026</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-may-05-2026-9</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-may-05-2026-9</guid>
<pubDate>Tue, 05 May 2026 14:03:41 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated May 05, 2026, titled "PRESS RELEASE REGARDING COMPANY S WHOLLY-OWNED SUBSIDIARY VIZ. CARBOGEN AMCIS (SHANGHAI) CO. LTD., SUCCESSFULLY COMPLETED AN UNANNOUNCED GOOD MANUFACTURING PRACTICE (GMP) INSPECTION BY CHINA S NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) FOR ITS SHANGHAI SITE, CHINA".</description>
</item>
<item>
<title>Press Release Feb 04 2026</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-feb-04-2026-47</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-feb-04-2026-47</guid>
<pubDate>Wed, 04 Feb 2026 21:59:36 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated February 04, 2026, titled "PRESS RELEASE ON UN-AUDITED FINANCIAL RESULT FOR THE THIRD QUARTER ENDED 31ST DECEMBER, 2025 REGULATIONS: 30 and 51".</description>
</item>
<item>
<title>Press Release Nov 12 2025</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-nov-12-2025-88</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-nov-12-2025-88</guid>
<pubDate>Wed, 12 Nov 2025 17:47:14 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "COMPANY S WHOLLY-OWNED SUBSIDIARY VIZ. CARBOGEN AMCIS HOLDING AG, ANNOUNCED SUCCESSFUL REFINANCING AND ENHANCEMENT OF THEIR SYNDICATED CREDIT FACILITIES TO SUPPORT CONTINUED GROWTH AND INVESTMENT".</description>
</item>
<item>
<title>Press Release Nov 05 2025</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-nov-05-2025-50</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-nov-05-2025-50</guid>
<pubDate>Thu, 06 Nov 2025 00:11:10 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "PRESS RELEASE ON UN-AUDITED FINANCIAL RESULT FOR THE SECOND QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER, 2025 ".</description>
</item>
<item>
<title>Press Release Oct 07 2025</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-oct-07-2025-20</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-oct-07-2025-20</guid>
<pubDate>Wed, 08 Oct 2025 00:01:49 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated October 07, 2025, titled "PRESS RELEASE REGARDING COMPANY S WHOLLY-OWNED SUBSIDIARY VIZ. CARBOGEN AMCIS AG, ANNOUNCED STRATEGIC ALLIANCE WITH CELONIC GROUP TO DELIVER FULLY INTEGRATED ADC DEVELOPMENT AND MANUFACTURING PLATFORM".</description>
</item>
<item>
<title>Press Release Jun 06 2025</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-jun-06-2025-9</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-jun-06-2025-9</guid>
<pubDate>Fri, 06 Jun 2025 18:47:21 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated Jun 06, 2025, titled "Announcement: Company s wholly-owned subsidiary viz. CARBOGEN AMCIS AG has entered into a Co-investment agreement with a long-standing Japan based customer to expand its ADC Manufacturing sites situated at Aarau and Neuland in Switzerland".</description>
</item>
<item>
<title>Press Release Apr 21 2025</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-apr-21-2025-15</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-apr-21-2025-15</guid>
<pubDate>Mon, 21 Apr 2025 23:28:27 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated April 21, 2025, titled "COMPANY S WHOLLY-OWNED SUBSIDIARY VIZ. CARBOGEN AMCIS (SHANGHAI) CO. LTD., RECEIVED DRUG MANUFACTURING LICENSE FROM THE NATIONAL MEDICAL PRODUCT ADMINISTRATION FOR ITS SHANGHAI SITE, CHINA".</description>
</item>
<item>
<title>Press Release Feb 03 2025</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-feb-03-2025-37</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-feb-03-2025-37</guid>
<pubDate>Mon, 03 Feb 2025 17:47:46 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated February 03, 2025, titled "MR. STEPHAN FRITSCHI APPOINTED AS NEW CHIEF EXECUTIVE OFFICER (CEO) OF CARBOGEN AMCIS ENTITIES, COMPANY S WHOLLY OWNED SUBSIDIARIES DUE TO DEPARTURE OF MR. PASCAL VILLEMAGNE, W.E.F. 1ST APRIL, 2025".</description>
</item>
<item>
<title>Press Release Jan 10 2025</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-jan-10-2025-9</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-jan-10-2025-9</guid>
<pubDate>Fri, 10 Jan 2025 18:45:53 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated January 10, 2025, titled "Dishman Carbogen Amcis Limited announces that its wholly owned subsidiary viz. CARBOGEN AMCIS AG has successfully completed Swissmedic Inspection of its Vionnaz facility, Switzerland".</description>
</item>
<item>
<title>Press Release Mar 18 2024</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-mar-18-2024-21</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-mar-18-2024-21</guid>
<pubDate>Mon, 18 Mar 2024 23:55:40 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated March 18, 2024, titled "Company s wholly owned subsidiary namely CARBOGEN AMCIS (Shanghai) Co Ltd, has successfully completed the Brazilian Regulatory Authority Agency (ANVISA) Audit of its site in Shanghai, China.".</description>
</item>
<item>
<title>Press Release Feb 10 2023</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-feb-10-2023-41</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-feb-10-2023-41</guid>
<pubDate>Sat, 11 Feb 2023 00:18:51 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated February 10, 2023, titled "PRESS RELEASE: UN-AUDITED FINANCIAL RESULT FOR THE THIRD QUARTER ENDED 31ST DECEMBER, 2022".</description>
</item>
<item>
<title>Press Release Feb 01 2023</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-feb-01-2023-27</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-feb-01-2023-27</guid>
<pubDate>Wed, 01 Feb 2023 19:56:03 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated February 01, 2023, titled "Announcement: Company s wholly-owned subsidiary viz. CARBOGEN AMCIS SAS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France".</description>
</item>
<item>
<title>Press Release Sep 28 2022</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-sep-28-2022-12</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-sep-28-2022-12</guid>
<pubDate>Wed, 28 Sep 2022 23:58:00 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange about press release dated 29-Sep-2022 titled Dishman Carbogen Amcis Ltd announces that its subsidiary, CARBOGEN AMCIS AG. has successfully completed Swissmedic inspection of its facility in Vionnaz, Switzerland</description>
</item>
<item>
<title>Press Release Mar 30 2022</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-mar-30-2022-18</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-mar-30-2022-18</guid>
<pubDate>Wed, 30 Mar 2022 20:23:26 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange about press release dated 31-Mar-2022 titled Mr. Pascal Villemagne appointed as new Chief Executive Officer (CEO) of CARBOGEN AMCIS entities, Company���s wholly owned subsidiaries</description>
</item>
<item>
<title>Press Release Dec 08 2021</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-dec-08-2021-19</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-dec-08-2021-19</guid>
<pubDate>Wed, 08 Dec 2021 16:51:34 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated December 08, 2021, titled "Company announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19".</description>
</item>
<item>
<title>Press Release Oct 28 2021</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-oct-28-2021-36</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-oct-28-2021-36</guid>
<pubDate>Thu, 28 Oct 2021 15:57:55 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated October 28, 2021, titled "Announcement: Company s wholly owned subsidiary viz. CARBOGEN AMCIS SAS alongwith NH TherAguix announces the release of a new batch of AGuIX Drug Product for clinical trials ".</description>
</item>
<item>
<title>Press Release Oct 27 2021</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-oct-27-2021-40</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-oct-27-2021-40</guid>
<pubDate>Wed, 27 Oct 2021 16:35:27 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated October 27, 2021, titled "Announcement: Company s wholly-owned subsidiary viz. CARBOGEN AMCIS AG. successfully completed U.S. FDA inspection of its facility in Aarau, Switzerland".</description>
</item>
<item>
<title>Press Release Aug 25 2021</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-aug-25-2021-10</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-aug-25-2021-10</guid>
<pubDate>Wed, 25 Aug 2021 04:10:59 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated August 24, 2021, titled "Announcement: Company s wholly-owned subsidiary viz. CARBOGEN AMCIS AG has signed a co-investment agreement of more than CHF 4 million with a long-standing Europe-based client ".</description>
</item>
<item>
<title>Press Release May 21 2021</title>
<link>https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-may-21-2021-13</link>
<guid isPermaLink="true">https://6ix.com/company/dishman-carbogen-amcis-limited/news/press-release-may-21-2021-13</guid>
<pubDate>Fri, 21 May 2021 18:05:30 GMT</pubDate>
<description>Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated May 21, 2021, titled "Successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency".</description>
</item>
</channel>
</rss>